18F-FMISO |
Hypoxia |
Voxelwise kinetic modeling |
Oncology/Prostate tumor |
Rat |
Bartlett et al. [23] |
Noninvasive pO2 measurement |
18F-FMISO |
- |
Kinetic model |
Oncology |
Rat |
Casciari et al. [64] |
3H-FMISO |
Monte Carlo simulations |
Patient |
18F-FMISO |
Hypoxia, perfusion |
Dynamic PET |
Oncology/Brain tumor |
Patient |
Bruehlmeier et al. [68] |
15O-H2O |
Kinetic models |
|
Logan graphical analysis |
18F-FMISO |
Hypoxia, perfusion |
Patlak graphical analysis |
Oncology/Spontaneous sarcomas |
Dog |
Bruehlmeier et al. [69] |
15O-H2O |
18F-FMISO |
Hypoxia |
Modular simulation |
Oncology/Model evaluation |
Simulation work |
Kelly and Brady et al. [65] |
Probability density function |
18F-FMISO |
Hypoxia |
Kinetic model |
Oncology/Model evaluation |
Phantom study |
Wang et al. [72] |
18F-FMISO |
Hypoxia |
Pharmacokinetic analysis |
Oncology/Head and neck cancer |
Patient |
Wang et al. [73] |
Dynamic PET/CT |
18F-FMISO |
Hypoxia, perfusion |
Dynamic PET |
Oncology/Head and neck cancer |
Patient |
Thorwarth et al. [70] |
Two compartment model |
18F-FMISO |
Hypoxia |
Dynamic PET |
Oncology/Radiotherapy |
Patient |
Thorwarth et al. [42] |
Two compartment model |
18F-FMISO |
Hypoxia |
DCE-MRI |
Oncology/Prostate tumor |
Rat |
Cho et al. [71] |
Dynamic PET |
Autoradiography |
18F-FMISO |
Hypoxia |
Dynamic PET |
Oncology/Non-immunogenic carcinoma |
Mouse |
Bejot et al. [67] |
18F-3-NTR |
Compartment modeling |
18F-FMISO |
Hypoxia |
Dynamic PET |
Scan protocol validation |
Mouse |
Whisenant et al. [66] |
18F-FDG |
Graphical analysis |
18F-FDG |
Graphical analysis |
18F-FMISO |
Stroke |
Dynamic PET |
Stroke |
Rat |
Takasawa et al. [74] |
18F-FMISO |
Hypoxia |
Dynamic PET |
Stroke |
Rat |
Hong et al. [75] |
Voxelwise Kinetic analysis based on basis function method |
18F-FETMIN |
Hypoxia |
Dynamic PET |
Oncology/Head and neck cancer |
Patient |
Lehtio et al. [80] |
Tumor to plasma ratio |
Tumor to plasma ratio |
18F-FETMIN |
Hypoxia |
Dynamic PET |
Oncology/Head and neck cancer |
Patient |
Lehtio et al. [81] |
Compartment analysis |
18F-FAZA |
Hypoxia |
Dynamic PET |
Oncology/Squamous cell carcinoma |
Mouse |
Busk et al. [87] |
Immunohistochemical staining |
Immunohistochemical staining |
18F-FAZA |
Hypoxia, perfusion |
Dynamic PET |
Oncology/Head and neck cancer |
Patient |
Shi et al. [88] |
15O-H2O |
Kinetic model |
18F-FAZA |
Hypoxia |
Dynamic PET/CT |
Oncology/No-small cell lung cancer |
Patient |
Verwer et al. [89] |
60Cu-ATSM |
Hypoxia |
Compartment analysis |
Myocardial ischemia |
Dog |
Lewis et al. [97] |
64Cu-ATSM |
64Cu-ATSM |
64Cu-ATSM |
Hypoxia |
Non-steady-state kinetic simulations |
Oncology/EMT6 murine carcinoma |
Mouse |
Holland et al. [100] |
61Cu-ATSM |
Hypoxia |
Electrochemical model |
Oncology/Head and neck cancer |
Patient |
Bowen et al. [101] |
18F-FMISO |
|
Transformation function |
|
|
pO2 microelectrode |
64Cu-ATSM |
Hypoxia |
Kinetic modeling |
Oncology/Radiotherapy |
Simulation work |
Dalah et al. [102] |
64Cu-ATSM |
Hypoxia |
Dynamic PET |
Oncology/Head and neck squamous cell carcinoma |
Rat |
McCall et al. [103] |
Autoradiography |
Immunohistochemical staining |
62Cu-PTSM |
Hypoxia, perfusion |
Dynamic PET |
Multiple tracer protocol |
Simulation work |
Rust et al. [104] |
62Cu-ATSM |
62Cu-ATSM |
62Cu-PTSM |
Hypoxia, perfusion |
Dynamic PET |
Multiple tracer protocol |
Dog |
Black et al. [105] |
62Cu-ATSM |
Compartment analysis |
Signal separation and recovery |
18F-FDG |
Hypoxia, perfusion and glycolysis |
Dynamic PET |
Multiple tracer protocol |
Dog |
Black et al. [106] |
62Cu-PTSM |
Compartment analysis |
Signal separation and recovery |
62Cu-ATSM |
|
|